Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1980 1
1982 2
1991 1
1994 1
1995 1
1996 1
1997 1
1999 1
2000 1
2001 2
2002 1
2003 2
2005 1
2006 4
2010 3
2011 1
2013 1
2014 2
2015 2
2017 1
2018 1
2019 1
2020 3
2021 4
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Update on the classification and treatment of localized scleroderma.
Bielsa Marsol I. Bielsa Marsol I. Actas Dermosifiliogr. 2013 Oct;104(8):654-66. doi: 10.1016/j.adengl.2012.10.012. Epub 2013 Aug 13. Actas Dermosifiliogr. 2013. PMID: 23948159 Free article. Review.
It comprises a number of subtypes differentiated according to their clinical presentation and the structure of the skin and underlying tissues involved in the fibrotic process. ...The main subtypes are plaque morphea, linear scleroderma, generalized morphea, …
It comprises a number of subtypes differentiated according to their clinical presentation and the structure of the skin and underlyin …
Generalized morphea treated with secukinumab.
Filoni A, Bonamonte D, Civino A, LA Torre F, Congedo M. Filoni A, et al. Ital J Dermatol Venerol. 2023 Aug;158(4):368-369. doi: 10.23736/S2784-8671.23.07502-3. Ital J Dermatol Venerol. 2023. PMID: 37539507 No abstract available.
Localized and systemic scleroderma.
Hawk A, English JC 3rd. Hawk A, et al. Semin Cutan Med Surg. 2001 Mar;20(1):27-37. doi: 10.1053/sder.2001.23093. Semin Cutan Med Surg. 2001. PMID: 11308134 Review.
Localized scleroderma is a cutaneous limited fibrosis that manifests as plaque morphea, generalized morphea, linear scleroderma, and deep morphea. Systemic scleroderma (sclerosis) can manifest as either limited or diffuse disease. ...This article discusses the class …
Localized scleroderma is a cutaneous limited fibrosis that manifests as plaque morphea, generalized morphea, linear scleroderm …
A case of eosinophilic fasciitis and generalized morphea overlap.
Watanabe Y, Yamamoto M, Yamamoto T. Watanabe Y, et al. Dermatol Online J. 2020 Feb 15;26(2):13030/qt96f64417. Dermatol Online J. 2020. PMID: 32239898 Free article. Review.
However, cases of concurrent eosinophilic fasciitis and generalized morphea are rare. In the present case, CD34 was differentially expressed in both lesions, suggesting eosinophilic fasciitis and morphea are separate diseases with different origin of mesenchymal cel …
However, cases of concurrent eosinophilic fasciitis and generalized morphea are rare. In the present case, CD34 was differenti …
Generalized morphea.
Strober BE. Strober BE. Dermatol Online J. 2003 Oct;9(4):24. Dermatol Online J. 2003. PMID: 14594597 Free article.
A 69-year-old man presented with symmetric erythematous, hyperpigmented, and ivory-colored plaques on the trunk and extremities. His clinical history, laboratory analysis, and histopathologic examination were consistent with generalized morphea, a subtype of …
A 69-year-old man presented with symmetric erythematous, hyperpigmented, and ivory-colored plaques on the trunk and extremities. His clin …
Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.
Antoñanzas J, Rodríguez-Garijo N, Estenaga Á, Morelló-Vicente A, España A, Aguado L. Antoñanzas J, et al. Dermatol Ther. 2022 Sep;35(9):e15709. doi: 10.1111/dth.15709. Epub 2022 Jul 20. Dermatol Ther. 2022. PMID: 35811413 Free PMC article. Review.
The aim of this article is to review the various hypotheses offered in the published literature about generalized morphea following vaccination. We present two cases of generalized morphea after COVID-19 vaccination and review the published literature …
The aim of this article is to review the various hypotheses offered in the published literature about generalized morphea foll …
Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations.
Chiu YE, Shmuylovich L, Kiguradze T, Anderson K, Sibbald C, Tollefson M, Kunzler E, Tom WL, Bond K, Ahmad RC, Garcia-Romero MT, Irfan M, Kollman K, Hunt R, Stein SL, Arkin L, Wong V, Pope E, Jacobe H, Brandling-Bennett HA, Cordoro KM, Bercovitch L, Rangel SM, Liu X, Szabo A, Paller AS. Chiu YE, et al. J Am Acad Dermatol. 2021 Jul;85(1):38-45. doi: 10.1016/j.jaad.2021.03.017. Epub 2021 Mar 6. J Am Acad Dermatol. 2021. PMID: 33689776
METHODS: A retrospective cross-sectional study was performed. Using clinical photographs, morphea lesions were mapped onto body diagrams using customized software. ...LIMITATIONS: Retrospective nature and the inclusion of only patients with clinical photographs. CON …
METHODS: A retrospective cross-sectional study was performed. Using clinical photographs, morphea lesions were mapped onto body diagr …
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
Arthur M, Fett NM, Latour E, Jacobe H, Kunzler E, Florez-Pollack S, Houser J, Sharma S, Prasad S, Femia A, Stern MJ, Pappas-Taffer LK, Gaffney R, Fernandez AP, Knabel D, Cardones AR, Leung N, Laumann A, Yu JM, Zhao J, Vleugels RA, Tkachenko E, Lo K. Arthur M, et al. JAMA Dermatol. 2020 May 1;156(5):521-528. doi: 10.1001/jamadermatol.2020.0035. JAMA Dermatol. 2020. PMID: 32236497 Free PMC article.
When this regimen is ineffective, not tolerated, or contraindicated, a trial of mycophenolate mofetil (MMF) or mycophenolic acid (MPA)-referred to herein as mycophenolate-is recommended; however, evidence to support this recommendation remains weak. ...RESULTS: There were …
When this regimen is ineffective, not tolerated, or contraindicated, a trial of mycophenolate mofetil (MMF) or mycophenolic acid (MPA …
Response of recalcitrant generalized morphea to intravenous immunoglobulins (IVIg): three cases and a review of the literature.
Kromer C, Mitterlechner L, Langer N, Schön MP, Mössner R. Kromer C, et al. Eur J Dermatol. 2021 Dec 1;31(6):822-829. doi: 10.1684/ejd.2021.4173. Eur J Dermatol. 2021. PMID: 35107073 Review.
BACKGROUND: Generalized morphea and eosinophilic fasciitis are difficult-to-treat inflammatory and sclerosing skin diseases. ...OBJECTIVES: We present three new patients with generalized morphea treated with intravenous immunoglobulins as well as a rev …
BACKGROUND: Generalized morphea and eosinophilic fasciitis are difficult-to-treat inflammatory and sclerosing skin diseases. . …
41 results